Antihypertensive and untoward effects of atenolol were studied in 20 cases of essential hypertension with their average pre-treatment systolic and diastolic blood pressures of approximately 160mmhg and 100mmhg, respectively. All patients were assigned to a single dose of 50mg atenolol once daily for a period of four weeks, and a weekly complete history and physical examination. Besides routine blood counts and urinalysis, blood chemistry relating to hepatic and renal functions, and electrolytes balance as well as fasting blood sugar levels were checked before and at the end of medication. In addition, in 10 cases, pulmonary function was studied before and after one week of treatment. With the therapy, the diastolic blood pressure fell to 90mmHg or below in 17 out of 20 cases(85%), and the pre-treatment diastolic blood pressure in the remaining three cases who responded poorly was 108mmHg or above. However two cases of the 17, who responded well and whose blood pressure became normal, had an initial diastolic pressure of 110mmHg each. The hypotensive effect of atenolol on both systolic and diastolic blood pressures was essentially similar, and the effect appeared during the first week with its peak effect occurring during the third week. There was no significant difference during treatment between recumbent and sitting blood pressures, both systolic and diastolic; thus no postural hypotension was observed. The comparison of the results of post-treatment laboratory tests with pre-treatment data revealed no significant changes. These suggest that atenolol can be used in patients with diabetes mellitus, chronic obstructive pulmonary disease or cerebral sclerosis, which are frquently associated with essential hypertension. Also a once-daily dose with satisfactory hypotensive response is one of very practical advantages of atenolol, particularly from the patient's point of view, in the treatment of hypertension, in which a life-long therapy is needed in most cases. Thus atenolol seems to be one of the most attractive choices of drugs for the treatment of mild to moderate hypertension.
Atenolol* ; Blood Glucose ; Blood Pressure ; Chemistry ; Diabetes Mellitus ; Electrolytes ; Fasting ; Humans ; Hypertension* ; Hypotension, Orthostatic ; Physical Examination ; Pulmonary Disease, Chronic Obstructive ; Tuberous Sclerosis ; Urinalysis

For the purpose of studying the compiarson of normal persons with patients with malignant tumors, the author investigated the incidence of epidermal cytoplasmic antibodies (EC-Ab) with sera taken from 15 normal persons, 38 patients with malignant tumors, and 2 patients with miscellaneous disorders by method of indirect immunofluorescence. The results were as follow: 1) .Positive reactions of EC-Ab were found in 2(13%) of 15 normal persons and 9 (24%) of 38 patients with malignant tumors. 2)Incidence of positive reactions of EC-Ab in various types of malignant turnors were found in 3(75%) of 4 patients with lung cancer, 2(40%) of 5 patients with rectal cancer, 3(13%) of 24 patients with stomach cancer, and 1(100%) patient with Hodgkins lymphoma. 3) Among 9 patients with malignant tumors of positive EC-Ab, 5 patients yielded the upper epiderrnaI cytoplasrnic (UEC) antibodies, 3 patients the general epidermal cytoplasmic (GEC) antibodies, and 1 patient basal cell layer (BCL) antibody. 4) A.mong 9 patients with malignant tumors of positive, the deposition of IgG was discovered in 7 patients, IgA in 1 patient and C, in 1 patient.
Antibodies* ; Cytoplasm* ; Fluorescent Antibody Technique, Indirect ; Hodgkin Disease ; Humans ; Immunoglobulin A ; Immunoglobulin G ; Incidence ; Lung Neoplasms ; Rectal Neoplasms ; Stomach Neoplasms

Red lunula, dusky red erythema of nailbed in the area of lunula, has ben reported in patients with alopecia areata and rheumatuid arthritis. We report a case of red lunula in a 63-year-old man. The patient showed dusky red, blanchable erythema of the lunula area in nailbecl of total fingernail, and toer.iails in association with hypertension due to nephrotic syndromc.
Alopecia Areata ; Arthritis ; Erythema ; Humans ; Hypertension ; Middle Aged ; Nails ; Nephrotic Syndrome*

Seventy-seven patients who were treated regularly for more than 5 years in the Taegu Leprosy Mission were investigated with regard to the change of the bacillary index(BI) after treatment of either dapsone(DDS) alone or a combination of DDS and clofazimine. The results were as follows: 1) In the group that took only DDS 400-500 mg per week, the BI conversion to negative took average 51 months. 2) In the group that took only 600-700 mg per week, the BI conversion to negative took average 34 months. 3) In the group that took only DDS 400 mg per week initially and 600-700mg per week secondarily, the BI conversion to negative took average 64 months, the last 33 months of which marked the time period that 600-700 mg were taken per week. 4) In the group that took only DDS 400-500mg per week initially and a combination of DDS gpp 700 mg per week and clofazimine. 3pp-4pp mg per week secondarily, the BI conversion to negative took average 63 months, the last 35 months of which marked the time period for the combined therapy. 5) In the group that took a combination of DDS 600- 700 mg per week and clofazimine 400 mg per week, the BI conversion to negative took average 42 months.
Clofazimine* ; Daegu ; Dapsone* ; Humans ; Leprosy* ; Missions and Missionaries

Antianginal and untoward effects of fenalcomine hydrochloride were studied in 24 cases of angina pectoris. Following discontinuation of all medications for 2 weeks except for liberal use of sublingual nitroglycerin for the relief of anginal attack, fenalcomine, 150mg a day in 3 divided doses, was given for 8 to 16 weeks. In 20 cases, routine blood counts including platelets, serum electrolytes and cholesterol as well as blood sugar level were checked before and at the completion of the medication. hepatic and renal functions were also studied. The effect of fenalcomine on severity, frequency and duration of anginal attack was excellent to good in 17 cases(70.9%), and was fair in 5 cases(20.8%). In the remaining 2 cases(8.3%), who responded poorly had angina pectoris for more than 3 years. It appeared that fenalcomine was similarly effective in those with or without associated hypertension or diabetes mellitus, or history of previous myocardial infarction. The comparison of the results of post-treatment laboratory tests with pre-treatment data revealed no significant changes. Furthermore, no untoward clinical reactions attributable to the drug was noted in all cases. These facts suggest that fenalcomine is a reliable and well tolerated antianginal agent which can be used singly or in combination with other agents.
Angina Pectoris ; Blood Glucose ; Cholesterol ; Diabetes Mellitus ; Electrolytes ; Hypertension ; Myocardial Infarction ; Nitroglycerin

No abstract available.
Animals ; Ischemia* ; Muscle, Skeletal* ; Rats* ; Reperfusion*

Underlying caustive diseases were observed on 108 patients with dementia diagnosed on DSM-III, who were admitted to Keimyung university Dongsan hospital during January 1985 to September 1988. The results were summarized as follows. 1. Male to female ratio was approximately 5 to 1. In all diseases causing dementia, male outnumbered female. In particular, alcoholic dementia, multi-infarct dementia, posttraumatic dementia, infection, hydrocephalus and subdural hematoma were almost limited to males. 2. The important causative diseases were alcoholic dementia (21.3%), multi-infarct dementia(18.5%), postanoxic encephalopathy (14.8%), dementia of Alzheimer type (12.1%), head trauma(8.3%), brain tumor (6.5%), pseudodementia(6.5%), infection(4.6%), hydrocephalus (4.6%), and subdural hematoma(2.8%) in the order of frequency. 3. Cerebral trauma was the most common cause of dementia in young adulthod, and alcoholic dementia, multiinfarct dementia and dementia of Alzheimer type were important in middle adulthood. In old age, multiinfarct dementia was noted to be the most common cause. 4. Thorough diagnostic evaluation has uncovered reversible disorders in 19.4% of the total patients and disorders which, though not reversible, nevertheless require active therapeutic intervention in an additional 60.2%.
Alcoholics ; Brain Neoplasms ; Dementia* ; Dementia, Multi-Infarct ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Head ; Hematoma, Subdural ; Humans ; Hydrocephalus ; Male

Appendicular schwannoma is a rare tumor originating from Schwann's cells in the Auerbach plexus. The preoperative diagnosis is difficult because the clinical features are nonspecific, and it is mostly found accidentally via a radiologic image as a tumor, mimicking malignancy. We report a case of an appendicular schwannoma coexisting with an adenocarcinoma in the lung. A laparoscopic appendectomy was done with a clear resection margin, and the immunohistochemical staining showed positive S-100 protein, which confirmed the schwannoma. The patient also underwent a left upper lobectomy of the lung. The patient has been free of recurrence for the 6 months since the operation. The laparoscopic approach could be available for treatment of an appendicular schwannoma, thus avoiding an unnecessary laparotomy.
Adenocarcinoma ; Appendectomy ; Appendix ; Humans ; Laparoscopy ; Laparotomy ; Lung ; Myenteric Plexus ; Neurilemmoma ; Recurrence ; S100 Proteins

From 1988 to 1994, 62 of 262 patients admitted to the Boramae City Hospital with gastric cancer were diagnosed as stage IV. Among them, 5 patients were lost during follow-up, so we analyzed 57 patients retrospectively. This study elucidates whether a palliative resection offered any survival advantage compared to non-resectional treatment. Of the 57 patients, 7 (12%) received a non-curative resection, 36 (63%) a bypass procedure, and 14 (25%) an exploratory laparotomy. There were no operative mortalities and morbidity. Univariate survival analysis demonstrated that the median survival and the 1- and the 2-year survival rates were significantly higher in the resected patients. The median survival and the 1- and the 2-year survival rates were 15 months, 71%, and 57% with a non-curative resection, 7.3 months, 25%, and 8% with bypass procedure, and 6.3 months 33%, and 17% with an exploratory laparotomy. To perform the analysis within relatively homogeneous groups, patients with different operations were further stratified into two groups according to the spread of disease: local (T4) and distant (M1) spread. The median survival of the T4 group was 11.4 months whereas that of the M1 group was 6 months. Although there was no statistical significance in this study, it is noteworthy that, compared to a bypass procedure and a exploratory laparotomy, a non-curative resection seems to have a survival benefit in the M1 group (median survival: 528 days vs 131 days and 182 days, p=0.0926). In conclusion, although this study has the limitations of a retrospective study and a univariate analysis performed without consideration of basic patient characteristics (age, weight loss, nutritional status, etc.), palliative resection seems to be justified in patients with stage IV gastric cancer if it is performed with acceptably low mortality and morbidity.
Follow-Up Studies ; Hospitals, Urban ; Humans ; Laparotomy ; Mortality ; Nutritional Status ; Retrospective Studies ; Stomach Neoplasms* ; Survival Rate ; Weight Loss

PURPOSE: Contrast-enhanced 3-D ultrafast MR angiography is a widely accepted MR imaging technique for theevaluation of the carotid artery, aorta, renal artery, mesenteric artery and portal venous system. To esti-mateitsclinical usefulness, single -and double- dose contrast-enhanced 3-D ultrafast pulmonary MR angiography wasassessed after a timing examination was performed. MATERIALS AND METHODS: Twenty volunteers underwentgadolinium-enhanced ultrafast pulmonary MR angiog-raphy( 3-D FISP, TR[msec]/TE[msec]=5.0/2.0, with 25 degrees flipangle). In ten volunteers(single-dose injection group) pulmonary MR angiography was performed after theadminstration of 0.1 mmol/kg(single dose injec-tion group), while the other ten(double-dose injection group) eachreceived, prior to angiography, 0.2 m m o l / kg. In all cases, a timing examination was performed during axialturbo-FLASH imaging(TR/TE/TI=8.5/4.0/100, 1 0 degree flip angle) after injection of the same dose as that used forsubsequent contrast-enhanced pulmonary MR angiography. In both groups, overall image quality, pulmonary arteryvisibility and contrast-to-noise ratio of the pulmonary artery were assessed on the basis of images obtained.RESULTS: With regard to overall image quality, there was no significant statistical difference between the twogroups (P>0.05), and in both, depiction of the central and lobar pulmonary artery was excellent. As regardsdepiction of the segmental artery, the average grading of the single dose injection group was 2.83 +/- 0.32, that ofthe double dose injection group was 2.85 +/-0.3, with no statistical significance(P>0.05). With respect tocon-trast-to-noise ratio of the central, lobar, and segmental arteries, the best results were obtained by thedouble dose injection group(P<0.05). CONCLUSION: Although the contrast-to-noise ratio in the double-dose injectiongroup was better than that in the single-dose group, differences in overall image quality and pulmoanry arterydepiction were not statistically significant. Thus, single-dose, contrast-enhanced 3-D ultrafast pulmonary MRangiography can provide useful images in clinical trials.
Angiography* ; Aorta ; Arteries ; Carotid Arteries ; Magnetic Resonance Imaging ; Mesenteric Arteries ; Pulmonary Artery ; Renal Artery ; Volunteers